Illumina (NASDAQ:ILMN) Price Target Raised to $126.00 at TD Cowen

Illumina (NASDAQ:ILMN – Free Report) had its price objective increased by TD Cowen from $122.00 to $126.00 in a report released on Wednesday morning, Benzinga reports. They currently have a hold rating on the life sciences company’s stock. ILMN has been the subject of a number of other research reports. Barclays raised their price objective […]

Leave a Reply

Your email address will not be published.

Previous post Prosperity Bancshares (NYSE:PB) Downgraded to Sell at StockNews.com
Next post IDEX (NYSE:IEX) PT Lowered to $230.00 at TD Cowen